Invitae Corporation (NVTA:NYSE) soared at $8.63, representing a gain of 276.9%. On Wed, Aug 10, 2022, NVTA:NYSE hit a New 2-Week High of $8.63. The stock appeared on our News Catalysts scanner on Tue, Aug 09, 2022 at 04:46 PM in the 'EARNINGS' category. From Wed, Jul 27, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Mon, Feb 28, 2022 at $11.4 with a volume of 8M+.
About Invitae Corporation (NVTA:NYSE)
Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions.
Top 10 Gainers:
- Invitae Corporation (NVTA:NYSE), 276.86%
- BioAtla Inc. (BCAB:NASDAQ), 83.1%
- Lixiang Education Holding Co. Ltd. (LXEH:NASDAQ), 49.03%
- Velo3D Inc. (VLD:NYSE), 42.02%
- Amyris, Inc. (AMRS:NASDAQ), 41.92%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 39.19%
- Euro Tech Holdings Company Limited (CLWT:NASDAQ), 38.36%
- Velodyne Lidar Inc. (VLDR:NASDAQ), 38.26%
- The Trade Desk, Inc. (TTD:NASDAQ), 36.22%
- V2X Inc. (VVX:NYSE), 33.21%